Our experimental work showed that SLC14A1 gene expression is an important factor involved in hypoxia-induced RCC development and progression, but evidence from large cohort studies on its expression and association with clinical outcomes is lacking. The gene discussed is SLC14A1; the disease is renal cell carcinoma.